UAMS Myeloma Institute to Create MDx Center, Endowed Chair with $10M Celgene Gift | GenomeWeb

NEW YORK (GenomeWeb) – Celgene has given the Myeloma Institute at the University of Arkansas for Medical Sciences $10 million to create the Bart Barlogie Center for Molecular Diagnostics and the Celgene Distinguished Endowed Chair for Molecular Therapeutics, the university announced on Monday.

Since the myeloma program at UAMS was founded in 1989, the school has seen more than 11,000 patients and performed more than 9,000 peripheral blood stem cell transplants, UAMS said. It further noted that since 2001, the number of myeloma survivors has increased by 57 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.